Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study

BACKGROUND: Retrospective studies suggest that low molecular weight heparin may delay the development of metastasis in patients with resected NSCLC. METHODS: Multicentre phase 3 study with patients with completely resected NSCLC who were randomised after surgery to receive chemotherapy with or witho...

Descripción completa

Detalles Bibliográficos
Autores principales: Groen, Harry J. M., van der Heijden, Erik H. F. M., Klinkenberg, Theo J., Biesma, Bonne, Aerts, Joachim, Verhagen, Ad, Kloosterziel, Corinne, Pieterman, Remge, van den Borne, Ben, Smit, Hans J. M., Hoekstra, Otto, Schramel, Frans M. N. H., van der Noort, Vincent, van Tinteren, Harm, Smit, Egbert F., Dingemans, Anne-Marie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738047/
https://www.ncbi.nlm.nih.gov/pubmed/31337877
http://dx.doi.org/10.1038/s41416-019-0533-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738047/
https://www.ncbi.nlm.nih.gov/pubmed/31337877
http://dx.doi.org/10.1038/s41416-019-0533-3

Ejemplares similares